SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-22-009957
Filing Date
2022-04-14
Accepted
2022-04-14 17:15:17
Documents
20

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 2611695
2 ex5-1.htm EX-5.1 100205
3 ex23-1.htm EX-23.1 7056
4 formdrs_001.jpg GRAPHIC 6805
5 formdrs_012.jpg GRAPHIC 53780
6 formdrs_014.jpg GRAPHIC 54422
7 formdrs_002.jpg GRAPHIC 54422
8 formdrs_003.jpg GRAPHIC 11468
9 formdrs_005.jpg GRAPHIC 18507
10 formdrs_007.jpg GRAPHIC 13811
11 chart_ogd.jpg GRAPHIC 25633
12 formdrs_008.jpg GRAPHIC 12952
13 formdrs_009.jpg GRAPHIC 15165
14 image_004.jpg GRAPHIC 22461
15 formdrs_011.jpg GRAPHIC 3041
16 ex23-1_001.jpg GRAPHIC 2024
17 ex23-1_002.jpg GRAPHIC 1649
18 ex5-1_001.jpg GRAPHIC 10980
19 ex5-1_002.jpg GRAPHIC 36866
20 ex5-1_003.jpg GRAPHIC 2160
  Complete submission text file 0001493152-22-009957.txt   3198442
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-263326 | Film No.: 22828220
SIC: 2836 Biological Products, (No Diagnostic Substances)